RENEE WIRUTH: Open Payments
NPI 1437811395 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 15 payments from 9 companies in 2025. Trend: 2023 $297 · 2024 $349 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $103 |
| ABBVIE INC. | 2 | $44 |
| Ardelyx, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, VRAYLAR, IBSRELA, BEXSERO, XIFAXAN, TZIELD, SHINGRIX, Wegovy.
Industry payments across AZ — which companies pay providers there.
